FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and TherapyLucie C. Kompier, Ellen C. Zwarthoff, Madelon N.M. van der Aa et al.|PLoS ONE|2010Cited by 314
The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate.Bas W.G. van Rhijn, Ellen C. Zwarthoff, Theodorus van der Kwast et al.|PubMed|2001Cited by 309
Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with OutcomeYves Allory, Francisco X. Real, Josep Lloreta et al.|European Urology|2013Cited by 289
A Simple and Fast Method for the Simultaneous Detection of Nine Fibroblast Growth Factor Receptor 3 Mutations in Bladder Cancer and Voided UrineJohanna M.M. van Oers, Ellen C. Zwarthoff, Irene Lurkin et al.|Clinical Cancer Research|2005Cited by 162
Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for CystoscopyKim E.M. van Kessel, Ellen C. Zwarthoff, Angelique Ziel‐van der Made et al.|The Journal of Urology|2016Cited by 154